Serveur d'exploration Tocilizumab - Analysis (France)

Index « Auteurs » - entrée « Daniel Wendling »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Daniel Teupser < Daniel Wendling < Daniel Windschall  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000126 (2019) Cécile Luxembourger [France] ; Adeline Ruyssen-Witrand [France] ; Chayma Ladhari [France] ; Cécile Rittore [France] ; Yannick Degboe [France] ; Jean-Francis Maillefert [France] ; Philippe Gaudin [France] ; Hubert Marotte [France] ; Daniel Wendling [France] ; Christian Jorgensen [France] ; Alain Cantagrel [France] ; Arnaud Constantin [France] ; Delphine Nigon [France] ; Isabelle Touitou [France] ; Jacques-Eric Gottenberg [France] ; Yves-Marie Pers [France]A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients.
000148 (2018) Sachiyo Oishi [France] ; Daniel Wendling [France] ; Jean Sibilia [France] ; Chantal Job-Deslandre [France] ; Loic Guillevin [France] ; Jacques Benichou [France] ; René Marc Flipo [France] ; Carole Duquenne [France] ; Francis Guillemin [France] ; Alain Saraux [France]Treatment of active rheumatoid arthritis: comparison of patients younger vs older than 75 years (CORPUS cohort)
000187 (2018) William Terreaux [France] ; Claire Masson [France] ; Jean-Paul Eschard [France] ; Thomas Bardin [France] ; Arnaud Constantin [France] ; Loïc Le Dantec [France] ; Christian Marcelli [France] ; Aleth Perdriger [France] ; Claire Scotto Di Fazano [France] ; Daniel Wendling [France] ; Jean Sibilia [France] ; Jacques Morel [France] ; Jean-Hugues Salmon [France]Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATE.
000195 (2018) Guillaume Moulis [France] ; Grégory Pugnet [France] ; Nathalie Costedoat-Chalumeau [France] ; Alexis Mathian [France] ; Gaëlle Leroux [France] ; Jonathan Boutémy [France] ; Olivier Espitia [France] ; Laurence Bouillet [France] ; Sabine Berthier [France] ; Jean-Baptiste Gaultier [France] ; Pierre-Yves Jeandel [France] ; Amadou Konaté [France] ; Arsène Mékinian [France] ; Elisabeth Solau-Gervais [France] ; Benjamin Terrier [France] ; Daniel Wendling [France] ; Fanny Andry [France] ; Camille Garnier [France] ; Pascal Cathébras [France] ; Laurent Arnaud [France] ; Aurore Palmaro [France] ; Patrice Cacoub [France] ; Zahir Amoura [France] ; Jean-Charles Piette [France] ; Philippe Arlet [France] ; Maryse Lapeyre-Mestre [France] ; Laurent Sailler [France]Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study.
000263 (2017) Xavier Guillot [France] ; Hélène Martin [France] ; Stéphanie Seguin-Py [France] ; Katy Maguin-Gaté [France] ; Johnny Moretto [France] ; Perle Totoson [France] ; Daniel Wendling [France] ; Céline Demougeot [France] ; Nicolas Tordi [France]Local cryotherapy improves adjuvant-induced arthritis through down-regulation of IL-6 / IL-17 pathway but independently of TNFα
000375 (2015) Clémentine Fortunet [France] ; Yves-Marie Pers [France] ; Joseph Lambert [France] ; Marie Godfrin-Valnet [France] ; Elodie Constant [France] ; Hervé Devilliers [France] ; Philippe Gaudin [France] ; Christian Jorgensen [France] ; Béatrice Pallot Prades [France] ; Daniel Wendling [France] ; Jean Francis Maillefert [France]Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice.
000383 (2015) Yves-Marie Pers [France] ; Marie Godfrin-Valnet ; Joseph Lambert ; Clémentine Fortunet ; Elodie Constant ; Thibault Mura ; Béatrice Pallot-Prades ; Christian Jorgensen ; Jean-Francis Maillefert ; Hubert Marotte ; Daniel Wendling ; Philippe GaudinResponse to tocilizumab in rheumatoid arthritis is not influenced by the body mass index of the patient.
000404 (2015) Yves-Marie Pers [France] ; Roxane Schaub [France] ; Elodie Constant [France] ; Joseph Lambert [France] ; Marie Godfrin-Valnet [France] ; Clémentine Fortunet [France] ; Waafa Bourichi [France] ; Béatrice Pallot Prades [France] ; Daniel Wendling [France] ; Philippe Gaudin [France] ; Christian Jorgensen [France] ; Jean-Francis Maillefert [France] ; Hubert Marotte [France]Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis.
000444 (2014) Yves-Marie Pers [France] ; Clémentine Fortunet ; Elodie Constant ; Joseph Lambert ; Marie Godfrin-Valnet ; Audrey De Jong ; Grégoire Mercier ; Béatrice Pallot Prades ; Daniel Wendling ; Philippe Gaudin ; Christian Jorgensen ; Hubert Marotte ; Jean-Francis MaillefertPredictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice.
000450 (2014) Claire Vidon [France] ; Marie Bossert [France] ; Anne Lohse-Walliser [France] ; Marie Godfrin-Valnet [France] ; Jean-Charles Balblanc [France] ; Daniel Wendling [France]Hair-cycle changes in two patients taking tocilizumab.
000470 (2014) Claire Vidon [France] ; Marie Bossert [France] ; Anne Lohse-Walliser [France] ; Marie Godfrin-Valnet [France] ; Jean-Charles Balblanc [France] ; Daniel Wendling [France]Trouble du cycle capillaire sous tocilizumab
000474 (2014) Daniel Wendling [France]Polyarthrite rhumatoïde: traitement
000489 (2013) Éric Toussirot [France] ; Émilie Grandclément [France] ; Béatrice Gaugler [France] ; Fabrice Michel [France] ; Daniel Wendling [France] ; Philippe Saas [France] ; Gilles Dumoulin [France]Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study
000500 (2013) Daniel Wendling [France] ; Claire Vidon ; Marie Godfrin-Valnet ; Gilles Rival ; Xavier Guillot ; Clément PratiExacerbation of combined pulmonary fibrosis and emphysema syndrome during tocilizumab therapy for rheumatoid arthritis.
000602 (2013) Daniel Wendling [France]Polyarthrite rhumatoïde: thérapeutique
000618 (2012) Fernando Kemta Lekpa [France] ; Cécile Poulain [France] ; Daniel Wendling [France] ; Martin Soubrier [France] ; Michel De Bandt [France] ; Jean Marie Berthelot [France] ; Philippe Gaudin [France] ; Eric Toussirot [France] ; Philippe Goupille [France] ; Thao Pham [France] ; Jérémie Sellam [France] ; Rémy Bruckert [France] ; Muriel Paul [France] ; Valérie Farrenq [France] ; Pascal Claudepierre [France]Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? a multicentre retrospective observational study
000645 (2012) Daniel Wendling [France]Thérapeutique des spondylarthrites: A l'ouest, rien de nouveau ?
000690 (2011) Daniel Wendling [France] ; Marie Bossert [France] ; Clément Prati [France]Effet à court terme de l'inhibition de l'IL-6 dans la spondylarthrite
000700 (2010-06) Thao Pham ; Pascal Claudepierre [France] ; Arnaud Constantin ; Michel De Bandt ; Bruno Fautrel [France] ; Laure Gossec [France] ; Jacques-Eric Gottenberg ; Philippe Goupille [France] ; Severine Guillaume [France] ; Eric Hachulla [France] ; Charles Masson ; Jacques Morel [France] ; Xavier Puechal ; Alain Saraux ; Thierry Schaeverbeke [France] ; Daniel Wendling ; Eric Bruckert [France] ; Stanislas Pol [France] ; Xavier Mariette [France] ; Jean SibiliaTocilizumab therapy and safety management
000703 (2010) Thao Pham [France] ; Pascal Claudepierre ; Arnaud Constantin ; Michel De Bandt ; Bruno Fautrel ; Laure Gossec ; Jacques-Eric Gottenberg ; Philippe Goupille ; Séverine Guillaume ; Eric Hachulla ; Charles Masson ; Jacques Morel ; Xavier Puéchal ; Alain Saraux ; Thierry Schaeverbeke ; Daniel Wendling ; Eric Bruckert ; Stanislas Pol ; Xavier Mariette ; Jean SibiliaTocilizumab: therapy and safety management.
000719 (2010) Daniel Wendling [France]Polyarthrite rhumatoïde: Thérapeutique

List of associated KwdEn.i

Nombre de
documents
Descripteur
11Humans
10Male
10Middle Aged
9Arthritis, Rheumatoid (drug therapy)
9Female
6Antibodies, Monoclonal, Humanized (therapeutic use)
6Retrospective Studies
6Rheumatology
6Treatment
6Treatment Outcome
5Adult
5Aged
5Antirheumatic Agents (therapeutic use)
5Immunomodulator
5Tocilizumab
4Chronic
4Immunosuppressive agent
4Rheumatoid arthritis
3Biotherapy
3Follow-Up Studies
3Tumor Necrosis Factor-alpha (antagonists & inhibitors)
2Antibodies, Monoclonal, Humanized (administration & dosage)
2Antibodies, Monoclonal, Humanized (adverse effects)
2Antineoplastic agent
2Drug Therapy, Combination
2Interleukin 6
2Spondylarthritis
2Tumor Necrosis Factor-alpha (metabolism)
1Abatacept
1Adalimumab
1Adrenal Cortex Hormones (therapeutic use)
1Alleles
1Alopecia
1Antibodies, Monoclonal (adverse effects)
1Antibodies, Monoclonal (therapeutic use)
1Antibodies, Monoclonal, Humanized
1Antibodies, Monoclonal, Humanized (metabolism)
1Antibodies, Monoclonal, Humanized (pharmacology)
1Antiinflammatory agent
1Antipsoriatic agent
1Antirheumatic Agents (adverse effects)
1Antirheumatic Agents (pharmacology)
1Antirheumatic agent
1Arthritis, Juvenile (drug therapy)
1Arthritis, Rheumatoid (complications)
1Arthritis, Rheumatoid (diagnosis)
1Arthritis, Rheumatoid (genetics)
1Arthritis, Rheumatoid (metabolism)
1Arthritis, Rheumatoid (physiopathology)
1Biological Products (adverse effects)
1Biological Products (therapeutic use)
1Body Mass Index
1California
1Contraindications
1Drug Administration Schedule
1Drug Delivery Systems (methods)
1Drug-Related Side Effects and Adverse Reactions (epidemiology)
1Drug-Related Side Effects and Adverse Reactions (etiology)
1Evidence-Based Medicine
1France (epidemiology)
1Genotype
1Glucocorticoids (administration & dosage)
1Glucocorticoids (therapeutic use)
1Hair
1Hair (drug effects)
1Hair (physiology)
1Incidence
1Infusions, Intravenous
1Interleukin 20
1Interleukin-6 (antagonists & inhibitors)
1Interleukin-6 (genetics)
1Interleukin-6 (metabolism)
1Mesenchymal cell
1Methotrexate
1Patient Education as Topic
1Polychondritis, Relapsing (drug therapy)
1Polymorphism, Single Nucleotide (genetics)
1Prednisolone
1Prednisone (therapeutic use)
1Prognosis
1Prospective Studies
1Pulmonary Emphysema (chemically induced)
1Pulmonary Emphysema (etiology)
1Pulmonary Fibrosis (chemically induced)
1Pulmonary Fibrosis (etiology)
1ROC Curve
1Receptors, Interleukin-6 (genetics)
1Registries
1Remission Induction
1Remission Induction (methods)
1Risk Factors
1Safety Management
1Severity of Illness Index
1Short term
1Spondylarthritis (drug therapy)
1Spondylarthritis (metabolism)
1Stem cell
1Time Factors
1West
1biologics

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Daniel Wendling" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Daniel Wendling" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Daniel Wendling
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021